• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症和游离 DNA 中的全基因组重复景观。

Genome-wide repeat landscapes in cancer and cell-free DNA.

机构信息

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

出版信息

Sci Transl Med. 2024 Mar 13;16(738):eadj9283. doi: 10.1126/scitranslmed.adj9283.

DOI:10.1126/scitranslmed.adj9283
PMID:38478628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11323656/
Abstract

Genetic changes in repetitive sequences are a hallmark of cancer and other diseases, but characterizing these has been challenging using standard sequencing approaches. We developed a de novo kmer finding approach, called ARTEMIS (Analysis of RepeaT EleMents in dISease), to identify repeat elements from whole-genome sequencing. Using this method, we analyzed 1.2 billion kmers in 2837 tissue and plasma samples from 1975 patients, including those with lung, breast, colorectal, ovarian, liver, gastric, head and neck, bladder, cervical, thyroid, or prostate cancer. We identified tumor-specific changes in these patients in 1280 repeat element types from the LINE, SINE, LTR, transposable element, and human satellite families. These included changes to known repeats and 820 elements that were not previously known to be altered in human cancer. Repeat elements were enriched in regions of driver genes, and their representation was altered by structural changes and epigenetic states. Machine learning analyses of genome-wide repeat landscapes and fragmentation profiles in cfDNA detected patients with early-stage lung or liver cancer in cross-validated and externally validated cohorts. In addition, these repeat landscapes could be used to noninvasively identify the tissue of origin of tumors. These analyses reveal widespread changes in repeat landscapes of human cancers and provide an approach for their detection and characterization that could benefit early detection and disease monitoring of patients with cancer.

摘要

遗传重复序列的变化是癌症和其他疾病的标志,但使用标准测序方法对其进行特征描述一直具有挑战性。我们开发了一种从头发现 kmer 的方法,称为 ARTEMIS(疾病中重复元素的分析),用于从全基因组测序中识别重复元素。使用这种方法,我们分析了来自 1975 名患者的 2837 个组织和血浆样本中的 12 亿个 kmer,其中包括肺癌、乳腺癌、结直肠癌、卵巢癌、肝癌、胃癌、头颈部癌、膀胱癌、宫颈癌、甲状腺癌或前列腺癌患者。我们在 1280 种 LINE、SINE、LTR、转座元件和人类卫星家族的重复元件类型中,在这些患者中发现了肿瘤特异性变化。其中包括已知重复元件的变化和 820 个以前在人类癌症中未发现改变的元件。重复元件在驱动基因区域富集,其表达受结构变化和表观遗传状态的影响。cfDNA 中全基因组重复景观和碎片化特征的机器学习分析在交叉验证和外部验证队列中检测到了早期肺癌或肝癌患者。此外,这些重复景观可用于无创性识别肿瘤的起源组织。这些分析揭示了人类癌症中重复景观的广泛变化,并提供了一种用于检测和特征描述的方法,可能有益于癌症患者的早期检测和疾病监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d35/11323656/9f2e59fff1ca/nihms-2001866-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d35/11323656/9d1daddd8b2c/nihms-2001866-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d35/11323656/2fc844273b75/nihms-2001866-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d35/11323656/6d3fa4a754b8/nihms-2001866-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d35/11323656/ebfa77c56ded/nihms-2001866-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d35/11323656/9f2e59fff1ca/nihms-2001866-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d35/11323656/9d1daddd8b2c/nihms-2001866-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d35/11323656/2fc844273b75/nihms-2001866-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d35/11323656/6d3fa4a754b8/nihms-2001866-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d35/11323656/ebfa77c56ded/nihms-2001866-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d35/11323656/9f2e59fff1ca/nihms-2001866-f0005.jpg

相似文献

1
Genome-wide repeat landscapes in cancer and cell-free DNA.癌症和游离 DNA 中的全基因组重复景观。
Sci Transl Med. 2024 Mar 13;16(738):eadj9283. doi: 10.1126/scitranslmed.adj9283.
2
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
3
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
4
Selenium for preventing cancer.硒预防癌症。
Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4.
5
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
6
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
7
Exploring potential therapeutic targets for colorectal tumors based on whole genome sequencing of colorectal tumors and paracancerous tissues.基于结直肠癌及癌旁组织全基因组测序探索结直肠癌潜在治疗靶点
Front Mol Biosci. 2025 Jul 4;12:1605117. doi: 10.3389/fmolb.2025.1605117. eCollection 2025.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
Short-Term Memory Impairment短期记忆障碍
10
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.

引用本文的文献

1
Repeatome Analysis of Plasma Circulating DNA in Patients with Cardiovascular Disease: Variation with Cell-Free DNA Integrity/Length and Clinical Parameters.心血管疾病患者血浆循环DNA的重复序列分析:与游离DNA完整性/长度及临床参数的关系
Int J Mol Sci. 2025 Jul 11;26(14):6657. doi: 10.3390/ijms26146657.
2
Comprehensive fragmentation of cell-free repetitive DNA for enhanced cancer detection in plasma.用于增强血浆中癌症检测的游离重复DNA的全面片段化
Front Cell Dev Biol. 2025 Jul 9;13:1630231. doi: 10.3389/fcell.2025.1630231. eCollection 2025.
3
Development and clinical applications of liquid biopsy assays in cancer screening.

本文引用的文献

1
Transposable elements as tissue-specific enhancers in cancers of endodermal lineage.转座元件作为内胚层谱系癌症中的组织特异性增强子。
Nat Commun. 2023 Sep 1;14(1):5313. doi: 10.1038/s41467-023-41081-4.
2
The complete sequence of a human Y chromosome.人类 Y 染色体的完整序列。
Nature. 2023 Sep;621(7978):344-354. doi: 10.1038/s41586-023-06457-y. Epub 2023 Aug 23.
3
Single-molecule genome-wide mutation profiles of cell-free DNA for non-invasive detection of cancer.基于游离 DNA 的单分子全基因组突变谱进行癌症的非侵入性检测。
液体活检检测在癌症筛查中的发展与临床应用
Transl Cancer Res. 2025 Jun 30;14(6):3846-3859. doi: 10.21037/tcr-2025-272. Epub 2025 Jun 13.
4
SERS-based detection of DNA methylation for cancer diagnosis: Cation-mediated adsorption to silver nanoparticles.基于表面增强拉曼光谱的DNA甲基化检测用于癌症诊断:阳离子介导吸附到银纳米颗粒上。
PLoS One. 2025 Jun 13;20(6):e0325539. doi: 10.1371/journal.pone.0325539. eCollection 2025.
5
Minimally invasive diagnosis of precancerous cervical lesions using single-cell peripheral immune atlas.利用单细胞外周免疫图谱对子宫颈癌前病变进行微创诊断。
Cell Rep Med. 2025 Jun 17;6(6):102149. doi: 10.1016/j.xcrm.2025.102149. Epub 2025 May 23.
6
Genome-wide analyses of cell-free DNA for therapeutic monitoring of patients with pancreatic cancer.用于胰腺癌患者治疗监测的游离DNA全基因组分析。
Sci Adv. 2025 May 23;11(21):eads5002. doi: 10.1126/sciadv.ads5002. Epub 2025 May 21.
7
Detection of Brain Cancer Using Genome-wide Cell-free DNA Fragmentomes.利用全基因组无细胞DNA片段组检测脑癌
Cancer Discov. 2025 Aug 4;15(8):1593-1608. doi: 10.1158/2159-8290.CD-25-0074.
8
Cell-Free DNA: Features and Attributes Shaping the Next Frontier in Liquid Biopsy.游离DNA:塑造液体活检下一个前沿领域的特征与属性
Mol Diagn Ther. 2025 May;29(3):277-290. doi: 10.1007/s40291-025-00773-x. Epub 2025 Apr 16.
9
Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection.用于早期癌症检测的游离DNA的基因组和片段组图谱。
Nat Rev Cancer. 2025 May;25(5):341-358. doi: 10.1038/s41568-025-00795-x. Epub 2025 Mar 4.
10
LINE-1 Retrotransposons as Cell-free DNA Biomarkers for Multicancer Early Detection.LINE-1反转录转座子作为多癌早期检测的游离DNA生物标志物
Clin Cancer Res. 2025 Apr 1;31(7):1179-1181. doi: 10.1158/1078-0432.CCR-24-4051.
Nat Genet. 2023 Aug;55(8):1301-1310. doi: 10.1038/s41588-023-01446-3. Epub 2023 Jul 27.
4
A draft human pangenome reference.人类泛基因组参考草图。
Nature. 2023 May;617(7960):312-324. doi: 10.1038/s41586-023-05896-x. Epub 2023 May 10.
5
Expression of down-regulated ERV LTR elements associates with immune activation in human small-cell lung cancers.下调的内源性逆转录病毒长末端重复序列元件的表达与人类小细胞肺癌中的免疫激活相关。
Mob DNA. 2023 Mar 14;14(1):2. doi: 10.1186/s13100-023-00290-w.
6
LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma.LINE-1 ORF1p 作为高级别浆液性卵巢癌的候选生物标志物。
Sci Rep. 2023 Jan 27;13(1):1537. doi: 10.1038/s41598-023-28840-5.
7
Recurrent repeat expansions in human cancer genomes.人类癌症基因组中的重复重复扩展。
Nature. 2023 Jan;613(7942):96-102. doi: 10.1038/s41586-022-05515-1. Epub 2022 Dec 14.
8
Detecting Liver Cancer Using Cell-Free DNA Fragmentomes.基于游离 DNA 片段组学检测肝癌
Cancer Discov. 2023 Mar 1;13(3):616-631. doi: 10.1158/2159-8290.CD-22-0659.
9
Epigenetic analysis of cell-free DNA by fragmentomic profiling.基于片段组学分析的游离 DNA 表观遗传学分析。
Proc Natl Acad Sci U S A. 2022 Nov;119(44):e2209852119. doi: 10.1073/pnas.2209852119. Epub 2022 Oct 26.
10
Repetitive Sequence Transcription in Breast Cancer.乳腺癌中的重复序列转录。
Cells. 2022 Aug 14;11(16):2522. doi: 10.3390/cells11162522.